IBRX - Immunitybio - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

IBRX is currently covered by 2 analysts with an average price target of $5.83. This is a potential upside of $0.37 (6.78%) from yesterday's end of day stock price of $5.46.

Immunitybio's activity chart (see below) currently has 16 price targets and 16 ratings on display. The stock rating distribution of IBRX is 60% BUY and 40% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.67% with an average time for these price targets to be met of 231.33 days.

Highest price target for IBRX is $5, Lowest price target is $5, average price target is $5.83.

Most recent stock forecast was given by JOSEPH CATANZARO from PIPER SANDLER on 25-Mar-2024. First documented stock forecast 16-May-2017.

Best performing analysts who are covering IBRX - Immunitybio:

Joseph Catanzaro Joel Beatty Kelly Shi

Currently out of the existing stock ratings of IBRX, 3 are a BUY (60%), 2 are a HOLD (40%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

5

$-0.46 (-8.42%)

4

3 days ago

2/8 (25%)

$-0.44 (-8.09%)

191

Buy

5

$-0.46 (-8.42%)

8

10 months 13 days ago

1/2 (50%)

$1.78 (55.28%)

226

Sell

0.8

$-4.66 (-85.35%)

1.25

4 years 9 months 26 days ago

4/5 (80%)

$-0.23 (-22.33%)

277

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IBRX (Immunitybio) average time for price targets to be met?

On average it took 231.33 days on average for the stock forecasts to be realized with a an average price target met ratio 51.67

Which analyst has the current highest performing score on IBRX (Immunitybio) with a proven track record?

JOSEPH CATANZARO

Which analyst has the current lower performing score on IBRX (Immunitybio) with a proven track record?

KELLY SHI

Which analyst has the most public recommendations on IBRX (Immunitybio)?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on IBRX

Which analyst is the currently most bullish on IBRX (Immunitybio)?

Kelly Shi with highest potential upside - $-0.46

Which analyst is the currently most reserved on IBRX (Immunitybio)?

Joel Beatty with lowest potential downside - -$4.66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?